🟢 Marker Therapeutics is trading 6% up today as XBI rises 2.06%

Marker Therapeutics is trading 6% up now at $1.59, appearing supported by stronger biotech sentiment as XBI rises 2.06%.

• The stock extended gains after closing at $1.50 on August 24, 2026.
• No new company-specific announcement was identified for August 25; speculative interest continues after H.C. Wainwright’s August 21 Buy reiteration and $10.00 price target.
• Several-session gains keep volatility and momentum trading important; confidence is medium because coverage is limited and no fresh direct catalyst was confirmed.